These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 22430596)

  • 1. Benign prostate hyperplasia: average volume in southwestern Nigerians and correlation with anthropometrics.
    Badmus TA; Asaleye CM; Badmus SA; Takure AO; Ibrahim MH; Arowolo OA
    Niger Postgrad Med J; 2012 Mar; 19(1):15-8. PubMed ID: 22430596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benign prostate hyperplasia: average volume in southwestern Nigerians and correlation with anthropometrics.
    Badmus TA; Asaleye CM; Badmus SA; Takure AO; Ibrahim MH; Arowolo OA
    Niger Postgrad Med J; 2013 Mar; 20(1):52-6. PubMed ID: 23661211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calculated fast-growing benign prostatic hyperplasia--a risk factor for developing clinical prostate cancer.
    Hammarsten J; Högstedt B
    Scand J Urol Nephrol; 2002; 36(5):330-8. PubMed ID: 12487736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient-reported outcomes in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) treated with intraprostatic OnabotulinumtoxinA: 3-month results of a prospective single-armed cohort study.
    Sacco E; Bientinesi R; Marangi F; Totaro A; D'Addessi A; Racioppi M; Pinto F; Vittori M; Bassi P
    BJU Int; 2012 Dec; 110(11 Pt C):E837-44. PubMed ID: 22712582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The correlation between obesity and prostate volume in patients with benign prostatic hyperplasia: A prospective cohort study.
    Negi SK; Desai S; Faujdar G; Jaiswal S; Sahu RD; Vyas N; Priyadarshi S
    Urologia; 2024 Aug; 91(3):512-517. PubMed ID: 38520295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationships between American Urological Association symptom index, prostate volume, and disease-specific quality of life question in patients with benign prostatic hyperplasia.
    Liu CC; Wang CJ; Huang SP; Chou YH; Wu WJ; Huang CH
    Kaohsiung J Med Sci; 2004 Jun; 20(6):273-8. PubMed ID: 15253468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of prostate-specific antigen and prostate volume in patients with biopsy proven benign prostatic hyperplasia.
    Hochberg DA; Armenakas NA; Fracchia JA
    Prostate; 2000 Dec; 45(4):315-9. PubMed ID: 11102956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Body Mass Index and Risk of Prostate Volume, International Prostate Symptom Score, Maximum Urinary Flow Rate, and Post-Void Residual in Benign Prostatic Hyperplasia Patients.
    Li BH; Deng T; Huang Q; Zi H; Weng H; Zeng XT
    Am J Mens Health; 2019; 13(4):1557988319870382. PubMed ID: 31426706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural history of lower urinary tract symptoms in Japanese men from a 15-year longitudinal community-based study.
    Fukuta F; Masumori N; Mori M; Tsukamoto T
    BJU Int; 2012 Oct; 110(7):1023-9. PubMed ID: 22233355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia.
    Hammarsten J; Högstedt B
    Eur Urol; 2001 Feb; 39(2):151-8. PubMed ID: 11223674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Correlation of serum prostate specific antigen, the volume and the intravesical prostatic protrusion for diagnosing bladder outlet obstruction in patients with benign prostate hyperplasia].
    Bantis A; Zissimopoulos A; Kalaytzis C; Giannakopoulos S; Sountoulides P; Agelonidou E; Voudalikakis C; Touloupidis S
    Hell J Nucl Med; 2007; 10(2):138-43. PubMed ID: 17684595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mid term outcomes of initial 250 case experience with GreenLight 120W-HPS photoselective vaporization prostatectomy for benign prostatic hyperplasia: comparison of prostate volumes < 60 cc, 60 cc-100 cc and > 100 cc.
    Hueber PA; Ben-Zvi T; Liberman D; Bhojani N; Gautam G; Deklaj T; Katz M; Zorn KC
    Can J Urol; 2012 Oct; 19(5):6450-8. PubMed ID: 23040627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Correlation of prostate peripheral zone thickness with benign prostatic hyperplasia/ lower urinary tract symptoms: An update].
    Kong B; Hou X; Yang JY
    Zhonghua Nan Ke Xue; 2019 Aug; 25(8):744-748. PubMed ID: 32227720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrasonically determined patterns of enlargement in benign prostatic hyperplasia.
    Collins GN; Lee RJ; Russell EB; Raab GM; Hehir M
    Br J Urol; 1993 Apr; 71(4):451-6. PubMed ID: 7684651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The correlation between metabolic syndrome and prostatic growth in patients with benign prostatic hyperplasia.
    Ozden C; Ozdal OL; Urgancioglu G; Koyuncu H; Gokkaya S; Memis A
    Eur Urol; 2007 Jan; 51(1):199-203; discussion 204-6. PubMed ID: 16806666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between erectile dysfunction and lower urinary tract symptoms due to benign prostatic hyperplasia in Nigerian men.
    Ikuerowo SO; Akindiji YO; Akinoso OA; Akinlusi FM; Esho JO
    Urol Int; 2008; 80(3):296-9. PubMed ID: 18480635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Nonspherical Polyvinyl Alcohol Particles and Microspheres for Prostatic Arterial Embolization in Patients with Benign Prostatic Hyperplasia.
    Hwang JH; Park SW; Chang IS; Jung SI; Jeon HJ; Lho YS; Kim HG; Paick SH; Park HK
    Biomed Res Int; 2017; 2017():8732351. PubMed ID: 28717651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adding Cyclooxygenase-2 inhibitor to alpha blocker for patients with benign prostate hyperplasia and elevated serum prostate specific antigen could not improve prostate biopsy detection rate but improve lower urinary tract symptoms.
    Jhang JF; Jiang YH; Kuo HC
    Int J Clin Pract; 2013 Dec; 67(12):1327-33. PubMed ID: 24246211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urine chemokines indicate pathogenic association of obesity with BPH/LUTS.
    Tyagi P; Motley SS; Kashyap M; Pore S; Gingrich J; Wang Z; Yoshimura N; Fowke JH
    Int Urol Nephrol; 2015 Jul; 47(7):1051-8. PubMed ID: 25924782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of BPH, lower urinary tract symptoms, and PSA levels on erectile function of Brazilian men who undergo prostate cancer screening.
    Antunes AA; Srougi M; Dall'oglio MF; Vicentini F; Paranhos M; Freire GC
    J Sex Med; 2008 Jul; 5(7):1702-7. PubMed ID: 18194186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.